Yixue Gu

1.6k total citations
40 papers, 1.1k citations indexed

About

Yixue Gu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yixue Gu has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Yixue Gu's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (7 papers). Yixue Gu is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (7 papers). Yixue Gu collaborates with scholars based in China, United States and Thailand. Yixue Gu's co-authors include Zhimin He, Guopei Zheng, Jiang Yin, Zhijie Zhang, Hao Liu, Xiaoting Jia, Minying Lu, Ying Song, Min Deng and Bo Peng and has published in prestigious journals such as PLoS ONE, Oncogene and Clinical Cancer Research.

In The Last Decade

Yixue Gu

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yixue Gu China 19 802 453 161 88 78 40 1.1k
Lucia Cappabianca Italy 19 570 0.7× 282 0.6× 185 1.1× 39 0.4× 62 0.8× 45 944
Ian G. Cannell United Kingdom 12 928 1.2× 555 1.2× 147 0.9× 51 0.6× 43 0.6× 15 1.2k
Lin Cai China 18 557 0.7× 376 0.8× 97 0.6× 29 0.3× 57 0.7× 39 1.0k
Vincenzo Dattilo Italy 19 581 0.7× 249 0.5× 78 0.5× 61 0.7× 37 0.5× 36 889
Radhika Raheja United States 13 465 0.6× 292 0.6× 89 0.6× 114 1.3× 21 0.3× 26 734
Chunqing Yang China 24 843 1.1× 564 1.2× 77 0.5× 23 0.3× 54 0.7× 50 1.1k
Amanda Gunn United States 8 928 1.2× 377 0.8× 216 1.3× 46 0.5× 52 0.7× 11 1.2k
Hongbo Wang China 16 471 0.6× 229 0.5× 98 0.6× 29 0.3× 144 1.8× 53 933
Kira T. Pate United States 8 739 0.9× 299 0.7× 242 1.5× 38 0.4× 66 0.8× 10 1.1k
Sara Caldarola Italy 15 704 0.9× 142 0.3× 191 1.2× 50 0.6× 35 0.4× 19 1.1k

Countries citing papers authored by Yixue Gu

Since Specialization
Citations

This map shows the geographic impact of Yixue Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixue Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixue Gu more than expected).

Fields of papers citing papers by Yixue Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixue Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixue Gu. The network helps show where Yixue Gu may publish in the future.

Co-authorship network of co-authors of Yixue Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yixue Gu. A scholar is included among the top collaborators of Yixue Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixue Gu. Yixue Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yahui, Jiang Chen, Ning‐Ning Zhang, et al.. (2025). Unveiling the significance of AKAP79/150 in the nervous system disorders: An emerging opportunity for future therapies?. Neurobiology of Disease. 206. 106812–106812.
2.
Zhang, Ningning, Sirui Chen, Jialing Jiang, et al.. (2025). Multiomic insights into the MPO-mediated NET formation pathway in alcohol-induced epilepsy risk. Genes & Diseases. 13(3). 101917–101917.
3.
Gu, Yixue, et al.. (2023). The Apelin/APJ system modulates seizure activity and endocytosis of the NMDA receptor GluN2B subunit. Neurochemistry International. 167. 105545–105545.
4.
Wei, Jing, Yuanyuan Chen, Yi Guo, et al.. (2022). Beclin1 Deficiency Suppresses Epileptic Seizures. Frontiers in Molecular Neuroscience. 15. 807671–807671. 9 indexed citations
5.
Wang, Yan, Yixue Gu, Yan Yin, et al.. (2022). Machine learning model to predict the efficacy of antiseizure medications in patients with familial genetic generalized epilepsy. Epilepsy Research. 181. 106888–106888. 7 indexed citations
6.
Xing, Shan, Zhi Tian, Wenying Zheng, et al.. (2021). Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1. Molecular Cancer. 20(1). 9–9. 62 indexed citations
7.
Zhang, Ke, Wenying Zheng, Ruixin Zhang, et al.. (2021). Long noncoding RNA SGO1-AS1 inactivates TGFβ signaling by facilitating TGFB1/2 mRNA decay and inhibits gastric carcinoma metastasis. Journal of Experimental & Clinical Cancer Research. 40(1). 342–342. 16 indexed citations
8.
Gu, Yixue, Meiling Wang, Yi Guo, et al.. (2020). Serum Exosomal Proteins F9 and TSP-1 as Potential Diagnostic Biomarkers for Newly Diagnosed Epilepsy. Frontiers in Neuroscience. 14. 737–737. 23 indexed citations
9.
Gu, Yixue, et al.. (2019). Epidemiology of Antibody-Positive Autoimmune Encephalitis in Southwest China: A Multicenter Study. Frontiers in Immunology. 10. 2611–2611. 53 indexed citations
10.
Yin, Jiang, Danyang Chen, Kai Luo, et al.. (2019). Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer. Journal of Cancer. 10(24). 5964–5974. 17 indexed citations
11.
Gu, Yixue, Hao Liu, Jiahui Ye, et al.. (2018). miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 164–164. 42 indexed citations
12.
Zheng, Guopei, Zhijie Zhang, Hao Liu, et al.. (2017). HSP27-Mediated Extracellular and Intracellular Signaling Pathways Synergistically Confer Chemoresistance in Squamous Cell Carcinoma of Tongue. Clinical Cancer Research. 24(5). 1163–1175. 30 indexed citations
13.
Zheng, Guopei, Nan Li, Xiaoting Jia, et al.. (2016). MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer. Journal of Molecular Medicine. 94(10). 1129–1141. 32 indexed citations
14.
Zheng, Guopei, Xiaoting Jia, Cong Peng, et al.. (2015). The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer. Oncotarget. 6(9). 6931–6943. 36 indexed citations
15.
Zheng, Guopei, Cong Peng, Xiaoting Jia, et al.. (2015). ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH. Molecular Cancer. 14(1). 84–84. 34 indexed citations
16.
Liu, Hao, Yixue Gu, Jiang Yin, et al.. (2014). SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell. Cellular Signalling. 26(12). 2710–2720. 34 indexed citations
17.
Deng, Min, et al.. (2013). Expression of microRNA-218 in nasopharyngeal carcinoma and its clinical significance. Tumori. 33(2). 1 indexed citations
18.
Peng, Bo, Yixue Gu, Yan Xiong, Guopei Zheng, & Zhimin He. (2012). Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma. PLoS ONE. 7(12). e51413–e51413. 29 indexed citations
19.
Wang, Chengkun, Jianguo Cao, Bo Peng, et al.. (2010). Inhibition of growth and motility of human A549 lung carcinoma cells by a recombined vascular basement membrane derived peptide. Cancer Letters. 292(2). 261–268. 7 indexed citations
20.
Wang, Chengkun, Jianguo Cao, Yafei Li, et al.. (2010). Recombinant vascular basement membrane derived multifunctional peptide blocks endothelial cell angiogenesis and neovascularization. Journal of Cellular Biochemistry. 111(2). 453–460. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026